Lumbar fusion outcomes stratified by specific diagnostic indication.

The influence of preoperative MRI findings on lumbar fusion clinical outcomes. Eur Spine J (2012) 1.52

Direct lateral access lumbar and thoracolumbar fusion: preliminary results. Eur Spine J (2012) 1.25

Comparative outcomes of minimally invasive surgery for posterior lumbar fusion: a systematic review. Clin Orthop Relat Res (2014) 1.24

Value and cost in less invasive spinal fusion surgery: lessons from a community hospital. SAS J (2010) 0.91

Economics of less invasive spinal surgery: an analysis of hospital cost differences between open and minimally invasive instrumented spinal fusion procedures during the perioperative period. Risk Manag Healthc Policy (2012) 0.89

Cost-utility analysis of posterior minimally invasive fusion compared with conventional open fusion for lumbar spondylolisthesis. SAS J (2011) 0.87

Long vs. short fusions for adult lumbar degenerative scoliosis: does balance matters? Eur Spine J (2015) 0.85

BMP-2 and TGF-β3 do not prevent spontaneous degeneration in rabbit disc explants but induce ossification of the annulus fibrosus. Eur Spine J (2012) 0.84

Comparison of clinical outcomes following minimally invasive lateral interbody fusion stratified by preoperative diagnosis. Eur Spine J (2015) 0.84

Lateral transpsoas fusion: indications and outcomes. ScientificWorldJournal (2012) 0.81

Substantial clinical benefit of minimally invasive lateral interbody fusion for degenerative spondylolisthesis. Eur Spine J (2015) 0.80

The 'Lumbar Fusion Outcome Score' (LUFOS): a new practical and surgically oriented grading system for preoperative prediction of surgical outcomes after lumbar spinal fusion in patients with degenerative disc disease and refractory chronic axial low back pain. Neurosurg Rev (2016) 0.80

Intervertebral disc rehydration after lumbar dynamic stabilization: magnetic resonance image evaluation with a mean followup of four years. Adv Orthop (2013) 0.79

Quality of life outcomes in surgically treated adult scoliosis patients: a systematic review. Eur Spine J (2014) 0.79

MyD88-dependent Toll-like receptor 4 signal pathway in intervertebral disc degeneration. Exp Ther Med (2016) 0.78

Lumbar fusion outcomes stratified by specific diagnostic indication. Spine J (2009) 0.76

ALIF and total disc replacement versus 2-level circumferential fusion with TLIF: a prospective, randomized, clinical and radiological trial. Eur Spine J (2015) 0.76

Impact of Surgical Approach on Clinical Outcomes in the Treatment of Lumbar Pseudarthrosis. Global Spine J (2016) 0.75

Minimally invasive laminectomy in spondylolisthetic lumbar stenosis. Ochsner J (2014) 0.75

Trunk Control Ability after Minimally Invasive Lumbar Fusion Surgery during the Early Postoperative Phase. J Phys Ther Sci (2014) 0.75

Disability and depression improve after lumbar discectomy, but may not change for other causes of back pain. Anesth Pain Med (2011) 0.75

Spine surgery outcome in patients who sought compensation after a motor vehicle accident: a retrospective cohort study. BMC Surg (2016) 0.75

Degenerative Scoliosis. Curr Rev Musculoskelet Med (2017) 0.75

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist (2007) 4.95

The impact of positive sagittal balance in adult spinal deformity. Spine (Phila Pa 1976) (2005) 4.76

Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales. Spine J (2008) 3.88

Perioperative complications of posterior lumbar decompression and arthrodesis in older adults. J Bone Joint Surg Am (2003) 3.75

Correlation of radiographic parameters and clinical symptoms in adult scoliosis. Spine (Phila Pa 1976) (2005) 3.37

Shock-synthesized hexagonal diamonds in Younger Dryas boundary sediments. Proc Natl Acad Sci U S A (2009) 3.33

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res (2002) 2.56

Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine (Phila Pa 1976) (2010) 2.24

Sagittal alignment of the spine and pelvis during growth. Spine (Phila Pa 1976) (2004) 2.18

Comparison of the EuroQOL-5D with the Oswestry Disability Index, back and leg pain scores in patients with degenerative lumbar spine pathology. Spine (Phila Pa 1976) (2013) 2.05

Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976) (2006) 1.95

Neck Disability Index, short form-36 physical component summary, and pain scales for neck and arm pain: the minimum clinically important difference and substantial clinical benefit after cervical spine fusion. Spine J (2010) 1.94

Two-year fusion and clinical outcomes in 224 patients treated with a single-level instrumented posterolateral fusion with iliac crest bone graft. Spine J (2009) 1.86

FDA drug approval summary: erlotinib (Tarceva) tablets. Oncologist (2005) 1.81

Genetic analysis of early holocene skeletal remains from Alaska and its implications for the settlement of the Americas. Am J Phys Anthropol (2007) 1.69

Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma. Clin Cancer Res (2007) 1.62

Posterior iliac crest pain after posterolateral fusion with or without iliac crest graft harvest. Spine J (2010) 1.61

Correlation of spinal canal dimensions to efficacy of epidural steroid injection in spinal stenosis. J Spinal Disord Tech (2007) 1.58

A prospective analysis of intraoperative electromyographic monitoring of posterior cervical screw fixation. J Spinal Disord Tech (2005) 1.57

Are preoperative health-related quality of life scores predictive of clinical outcomes after lumbar fusion? Spine (Phila Pa 1976) (2009) 1.56

Treatment of pyogenic vertebral osteomyelitis with anterior debridement and fusion followed by delayed posterior spinal fusion. Spine (Phila Pa 1976) (2004) 1.55

Defining substantial clinical benefit following lumbar spine arthrodesis. J Bone Joint Surg Am (2008) 1.55

The influence of preoperative MRI findings on lumbar fusion clinical outcomes. Eur Spine J (2012) 1.52

The impact of perioperative complications on clinical outcome in adult deformity surgery. Spine (Phila Pa 1976) (2007) 1.43

Surgical management of adjacent level degeneration following lumbar spine fusion. Orthopedics (2002) 1.41

The Reliability and Validity of the Thoracolumbar Injury Classification System in Pediatric Spine Trauma. Spine (Phila Pa 1976) (2015) 1.40

Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. J Bone Joint Surg Am (2009) 1.39

FDA drug approval summaries: pemetrexed (Alimta). Oncologist (2004) 1.37

RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age. Spine (Phila Pa 1976) (2008) 1.35

The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion. Spine J (2007) 1.34

Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res (2005) 1.28

Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J (2006) 1.27

Clinical outcomes in older patients after posterolateral lumbar fusion. Spine J (2007) 1.25

Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine (Phila Pa 1976) (2005) 1.24

Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC). Oncologist (2010) 1.24

Non-neurologic complications following surgery for adolescent idiopathic scoliosis. J Bone Joint Surg Am (2007) 1.22

Classification of congenital scoliosis and kyphosis: a new approach to the three-dimensional classification for progressive vertebral anomalies requiring operative treatment. Spine (Phila Pa 1976) (2009) 1.22

Native American mtDNA prehistory in the American Southwest. Am J Phys Anthropol (2003) 1.21

Diagnostic accuracy and reliability of fine-cut CT scans with reconstructions to determine the status of an instrumented posterolateral fusion with surgical exploration as reference standard. Spine (Phila Pa 1976) (2007) 1.21

The effect of obesity on clinical outcomes after lumbar fusion. Spine (Phila Pa 1976) (2008) 1.19

Perioperative complications of lumbar instrumentation and fusion in patients with diabetes mellitus. Spine J (2003) 1.19

Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion. Spine (Phila Pa 1976) (2005) 1.19

The role of SN-38 exposure, UGT1A1*28 polymorphism, and baseline bilirubin level in predicting severe irinotecan toxicity. J Clin Pharmacol (2007) 1.16

The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers. Spine (Phila Pa 1976) (2007) 1.14

The costs and benefits of nonoperative management for adult scoliosis. Spine (Phila Pa 1976) (2010) 1.14

The structure of diversity within New World mitochondrial DNA haplogroups: implications for the prehistory of North America. Am J Hum Genet (2002) 1.12

FDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancer. Oncologist (2005) 1.12

Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas. Oncology (Williston Park) (2007) 1.11

The cost effectiveness of single-level instrumented posterolateral lumbar fusion at 5 years after surgery. Spine (Phila Pa 1976) (2012) 1.10

U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval. Clin Cancer Res (2005) 1.10

Assessment of spine surgery outcomes: inconsistency of change amongst outcome measurements. Spine J (2010) 1.09

Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion. Eur Spine J (2010) 1.08

Relationship among United States Medical Licensing Step I, orthopedic in-training, subjective clinical performance evaluations, and american board of orthopedic surgery examination scores: a 12-year review of an orthopedic surgery residency program. J Surg Educ (2010) 1.08

Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis. Spine (Phila Pa 1976) (2009) 1.08

Pediatric spine fractures: a review of 137 hospital admissions. J Spinal Disord Tech (2004) 1.06

Review of oncology and hematology drug product approvals at the US Food and Drug Administration between July 2005 and December 2007. J Natl Cancer Inst (2010) 1.04

Pemetrexed in malignant pleural mesothelioma. Clin Cancer Res (2005) 1.04

Reliability and agreement between fine-cut CT scans and plain radiography in the evaluation of posterolateral fusions. Spine J (2006) 1.02

Outcome of lumbar arthrodesis in patients sixty-five years of age or older. J Bone Joint Surg Am (2009) 1.01

Intra- and inter-observer reliability of determining radiographic sagittal parameters of the spine and pelvis using a manual and a computer-assisted methods. Eur Spine J (2008) 1.00